CA1238548A - Respirateur a phase inspiratoire oscillatoire et methode - Google Patents

Respirateur a phase inspiratoire oscillatoire et methode

Info

Publication number: CA1238548A
Authority: CA; Canada
Prior art keywords: outlet; inlet; gas; oscillator; ventilator
Prior art date: 1983-07-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000446110A

Other languages

English (en)

Inventor

Forrest M. Bird

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bird F M

Original Assignee

Bird F M

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-07-21

Filing date

1984-01-26

Publication date

1988-06-28

1983-07-21 Priority claimed from US06/516,133 external-priority patent/US4592349A/en

1984-01-26 Application filed by Bird F M filed Critical Bird F M

1988-06-28 Application granted granted Critical

1988-06-28 Publication of CA1238548A publication Critical patent/CA1238548A/fr

Status Expired legal-status Critical Current

Links

230000003434 inspiratory effect Effects 0.000 title claims description 201
230000003534 oscillatory effect Effects 0.000 title description 103
238000000034 method Methods 0.000 title description 38
239000007789 gas Substances 0.000 claims abstract description 773
238000009423 ventilation Methods 0.000 claims abstract description 55
239000006199 nebulizer Substances 0.000 claims description 129
230000029058 respiratory gaseous exchange Effects 0.000 claims description 98
230000010355 oscillation Effects 0.000 claims description 64
210000004072 lung Anatomy 0.000 claims description 53
238000004891 communication Methods 0.000 claims description 28
230000006854 communication Effects 0.000 claims description 28
230000001351 cycling effect Effects 0.000 claims description 28
230000008878 coupling Effects 0.000 claims description 24
238000010168 coupling process Methods 0.000 claims description 24
238000005859 coupling reaction Methods 0.000 claims description 24
239000007788 liquid Substances 0.000 claims description 22
239000000443 aerosol Substances 0.000 claims description 16
229940079593 drug Drugs 0.000 claims description 15
239000003814 drug Substances 0.000 claims description 15
230000007704 transition Effects 0.000 claims description 14
230000035945 sensitivity Effects 0.000 claims description 9
229940000425 combination drug Drugs 0.000 claims description 5
230000002708 enhancing effect Effects 0.000 claims description 2
230000000541 pulsatile effect Effects 0.000 abstract description 37
229940090045 cartridge Drugs 0.000 description 505
210000000188 diaphragm Anatomy 0.000 description 107
238000002955 isolation Methods 0.000 description 70
238000009792 diffusion process Methods 0.000 description 52
239000003570 air Substances 0.000 description 40
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
229910001868 water Inorganic materials 0.000 description 37
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 35
229910052760 oxygen Inorganic materials 0.000 description 35
239000001301 oxygen Substances 0.000 description 35
230000001105 regulatory effect Effects 0.000 description 33
230000001965 increasing effect Effects 0.000 description 21
230000006837 decompression Effects 0.000 description 20
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 18
239000012298 atmosphere Substances 0.000 description 18
238000011068 loading method Methods 0.000 description 17
230000032258 transport Effects 0.000 description 16
230000000712 assembly Effects 0.000 description 15
238000000429 assembly Methods 0.000 description 15
238000002663 nebulization Methods 0.000 description 14
230000006870 function Effects 0.000 description 13
230000003519 ventilatory effect Effects 0.000 description 13
230000002685 pulmonary effect Effects 0.000 description 12
239000012080 ambient air Substances 0.000 description 11
239000008280 blood Substances 0.000 description 11
210000004369 blood Anatomy 0.000 description 11
239000002360 explosive Substances 0.000 description 11
239000000463 material Substances 0.000 description 11
230000008901 benefit Effects 0.000 description 10
229910002092 carbon dioxide Inorganic materials 0.000 description 10
230000003247 decreasing effect Effects 0.000 description 10
238000010586 diagram Methods 0.000 description 10
239000004033 plastic Substances 0.000 description 10
229920003023 plastic Polymers 0.000 description 10
230000002829 reductive effect Effects 0.000 description 10
210000003414 extremity Anatomy 0.000 description 9
150000002500 ions Chemical class 0.000 description 9
241000239290 Araneae Species 0.000 description 8
230000000994 depressogenic effect Effects 0.000 description 8
230000000694 effects Effects 0.000 description 8
238000002156 mixing Methods 0.000 description 8
238000012544 monitoring process Methods 0.000 description 8
RZZGGSCKACYXBQ-UHFFFAOYSA-N 3,5,6,7,8,9-hexahydro-2h-cyclohepta[c]pyridazin-3-ylhydrazine Chemical compound C1CCCCC2=CC(NN)NN=C21 RZZGGSCKACYXBQ-UHFFFAOYSA-N 0.000 description 7
239000001569 carbon dioxide Substances 0.000 description 7
230000001276 controlling effect Effects 0.000 description 7
125000004122 cyclic group Chemical group 0.000 description 7
230000009975 flexible effect Effects 0.000 description 7
230000036961 partial effect Effects 0.000 description 7
208000036366 Sensation of pressure Diseases 0.000 description 6
230000007423 decrease Effects 0.000 description 6
239000002245 particle Substances 0.000 description 6
230000002441 reversible effect Effects 0.000 description 6
230000002269 spontaneous effect Effects 0.000 description 6
230000009471 action Effects 0.000 description 5
230000000740 bleeding effect Effects 0.000 description 5
238000010276 construction Methods 0.000 description 5
230000009977 dual effect Effects 0.000 description 5
230000000670 limiting effect Effects 0.000 description 5
244000144985 peep Species 0.000 description 5
230000000737 periodic effect Effects 0.000 description 5
230000000241 respiratory effect Effects 0.000 description 5
230000000717 retained effect Effects 0.000 description 5
230000002459 sustained effect Effects 0.000 description 5
210000001364 upper extremity Anatomy 0.000 description 5
ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical class OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 4
230000004224 protection Effects 0.000 description 4
230000009467 reduction Effects 0.000 description 4
238000013022 venting Methods 0.000 description 4
230000002612 cardiopulmonary effect Effects 0.000 description 3
230000000881 depressing effect Effects 0.000 description 3
238000009826 distribution Methods 0.000 description 3
230000004927 fusion Effects 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
210000003141 lower extremity Anatomy 0.000 description 3
239000000203 mixture Substances 0.000 description 3
238000010926 purge Methods 0.000 description 3
230000006641 stabilisation Effects 0.000 description 3
238000011105 stabilization Methods 0.000 description 3
230000008093 supporting effect Effects 0.000 description 3
230000000007 visual effect Effects 0.000 description 3
206010061688 Barotrauma Diseases 0.000 description 2
102100031272 Calcineurin B homologous protein 2 Human genes 0.000 description 2
241001510512 Chlamydia phage 2 Species 0.000 description 2
101000777239 Homo sapiens Calcineurin B homologous protein 2 Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
230000002730 additional effect Effects 0.000 description 2
230000000747 cardiac effect Effects 0.000 description 2
229920001971 elastomer Polymers 0.000 description 2
229920002457 flexible plastic Polymers 0.000 description 2
230000000870 hyperventilation Effects 0.000 description 2
208000000122 hyperventilation Diseases 0.000 description 2
208000014674 injury Diseases 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
239000002184 metal Substances 0.000 description 2
239000003595 mist Substances 0.000 description 2
230000001483 mobilizing effect Effects 0.000 description 2
NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 2
230000037361 pathway Effects 0.000 description 2
230000001630 postinspiratory effect Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000010349 pulsation Effects 0.000 description 2
230000003252 repetitive effect Effects 0.000 description 2
230000004202 respiratory function Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
229920000260 silastic Polymers 0.000 description 2
239000000243 solution Substances 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
230000008733 trauma Effects 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
229930182837 (R)-adrenaline Natural products 0.000 description 1
206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
241000331231 Amorphocerini gen. n. 1 DAD-2008 Species 0.000 description 1
XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
229910000906 Bronze Inorganic materials 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
206010007556 Cardiac failure acute Diseases 0.000 description 1
235000006696 Catha edulis Nutrition 0.000 description 1
240000007681 Catha edulis Species 0.000 description 1
201000006306 Cor pulmonale Diseases 0.000 description 1
244000187656 Eucalyptus cornuta Species 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
229920004142 LEXAN™ Polymers 0.000 description 1
239000004418 Lexan Substances 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229920006074 Nylatron® Polymers 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000011623 Obstructive Lung disease Diseases 0.000 description 1
241001230134 Phasis Species 0.000 description 1
244000273256 Phragmites communis Species 0.000 description 1
235000014676 Phragmites communis Nutrition 0.000 description 1
206010036590 Premature baby Diseases 0.000 description 1
208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
206010039897 Sedation Diseases 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
238000012387 aerosolization Methods 0.000 description 1
229940094070 ambien Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000010974 bronze Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
239000013536 elastomeric material Substances 0.000 description 1
229960005139 epinephrine Drugs 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000009499 grossing Methods 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000016507 interphase Effects 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
238000007726 management method Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
239000002674 ointment Substances 0.000 description 1
238000009527 percussion Methods 0.000 description 1
108010033574 phasin Proteins 0.000 description 1
230000006461 physiological response Effects 0.000 description 1
229920001084 poly(chloroprene) Polymers 0.000 description 1
XXPDBLUZJRXNNZ-UHFFFAOYSA-N promethazine hydrochloride Chemical compound Cl.C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 XXPDBLUZJRXNNZ-UHFFFAOYSA-N 0.000 description 1
239000002516 radical scavenger Substances 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
230000002000 scavenging effect Effects 0.000 description 1
238000007789 sealing Methods 0.000 description 1
230000036280 sedation Effects 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000003466 welding Methods 0.000 description 1
ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 1

Landscapes

Respiratory Apparatuses And Protective Means (AREA)

CA000446110A 1983-07-21 1984-01-26 Respirateur a phase inspiratoire oscillatoire et methode Expired CA1238548A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US516,133		1983-07-21
US06/516,133 US4592349A (en)	1981-08-10	1983-07-21	Ventilator having an oscillatory inspiratory phase and method

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000563456A Division CA1282809C (fr)	1983-07-21	1988-04-06	Dispositif de desaccouplement eclair

Publications (1)

Publication Number	Publication Date
CA1238548A true CA1238548A (fr)	1988-06-28

Family

ID=24054267

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CA000446110A Expired CA1238548A (fr)	1983-07-21	1984-01-26	Respirateur a phase inspiratoire oscillatoire et methode
CA000563456A Expired - Lifetime CA1282809C (fr)	1983-07-21	1988-04-06	Dispositif de desaccouplement eclair
CA000598775A Expired - Lifetime CA1292658C (fr)	1983-07-21	1989-05-04	Ventilateur a phase inspiratoire oscillante et methode connexe

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CA000563456A Expired - Lifetime CA1282809C (fr)	1983-07-21	1988-04-06	Dispositif de desaccouplement eclair
CA000598775A Expired - Lifetime CA1292658C (fr)	1983-07-21	1989-05-04	Ventilateur a phase inspiratoire oscillante et methode connexe

Country Status (1)

Country	Link
CA (3)	CA1238548A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108652632A (zh) *	2017-03-31	2018-10-16	张政波	强迫振荡肺功能测试装置及方法
CN116832284A (zh) *	2023-07-17	2023-10-03	广州医科大学附属第一医院（广州呼吸中心）	肺廓清装置
CN118649328A (zh) *	2024-08-20	2024-09-17	江苏苏云医疗器材有限公司	一种输氧引导分流组件

1984
- 1984-01-26 CA CA000446110A patent/CA1238548A/fr not_active Expired
1988
- 1988-04-06 CA CA000563456A patent/CA1282809C/fr not_active Expired - Lifetime
1989
- 1989-05-04 CA CA000598775A patent/CA1292658C/fr not_active Expired - Lifetime

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108652632A (zh) *	2017-03-31	2018-10-16	张政波	强迫振荡肺功能测试装置及方法
CN108652632B (zh) *	2017-03-31	2023-07-14	中国人民解放军总医院	强迫振荡肺功能测试装置及方法
CN116832284A (zh) *	2023-07-17	2023-10-03	广州医科大学附属第一医院（广州呼吸中心）	肺廓清装置
CN118649328A (zh) *	2024-08-20	2024-09-17	江苏苏云医疗器材有限公司	一种输氧引导分流组件

Also Published As

Publication number	Publication date
CA1282809C (fr)	1991-04-09
CA1292658C (fr)	1991-12-03

Legal Events

Date	Code	Title	Description
2005-06-28	MKEX	Expiry

Publication	Publication Date	Title
US4592349A (en)	1986-06-03	Ventilator having an oscillatory inspiratory phase and method
US5116088A (en)	1992-05-26	Ventilator having an oscillatory inspiratory phase and method
US5862802A (en)	1999-01-26	Ventilator having an oscillatory inspiratory phase and method
US5007420A (en)	1991-04-16	Ventilator having an oscillatory inspiratory phase and method
US4121579A (en)	1978-10-24	Ventilator and method
US4039139A (en)	1977-08-02	Ventilator and method
US3933171A (en)	1976-01-20	Anesthesia breathing circuit with positive end expiratory pressure valve
US4198969A (en)	1980-04-22	Suction-operated nebulizer
US6067984A (en)	2000-05-30	Pulmonary modulator apparatus
US4141354A (en)	1979-02-27	Ventilator system for controlling, assisting and monitoring a patient's breathing
EP1357880B1 (fr)	2012-06-06	Appareil permettant la ventilation par percussion intermittente et ensemble a tete respiratoire individuelle utilisable dans ce dernier
US4596247A (en)	1986-06-24	Respirator
US4051847A (en)	1977-10-04	Anesthesia rebreathing apparatus
EP0383069B1 (fr)	1994-11-02	Respirateur/réanimateur d'urgence complètement autonome, portable et individualisé
EP1414527B1 (fr)	2014-01-22	Appareil d'interface pour respirateur de type volumetrique mecanique continu et ventilateur a percussion intra-pulmonaire, combinaison de ceux-ci
US5165398A (en)	1992-11-24	Ventilator and oscillator for use therewith and method
US4060078A (en)	1977-11-29	Ventilator and method
US4164219A (en)	1979-08-14	Ventilator
US3726274A (en)	1973-04-10	Non-rebreathing valve assembly and compression bulb resuscitator using same
US4805613A (en)	1989-02-21	Ventilator which can be readily transported for emergency situations
US3831595A (en)	1974-08-27	Respirator
CA1103118A (fr)	1981-06-16	Appareil combine pour l'administration de l'anesthesie et de soins intensifs
US5492115A (en)	1996-02-20	Resuscitation breathing apparatus
US5979443A (en)	1999-11-09	Closed ventilation/anesthesia apparatus
JPH05123402A (ja)	1993-05-21	噴流換気システム